Records containing: Ulcerative Colitis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-09-28A Comprehensive Self-Management Intervention for Individuals With Inflammatory Bowel Disease
-
CLINICAL_TRIALS study record update · 2026-09-17A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects With Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2026-06-03A Multicenter, Phase 3, Open-Label Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mirikizumab in Participants 2 Years to Less Than 18 Years of Age With Moderately to Severely Active Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2026-06-03Phase 3b, Multicenter, Randomized, Open-Label Study of Risankizumab Compared to Vedolizumab for the Treatment of Adult Subjects With Moderate to Severe Ulcerative Colitis Who Are Naïve to Targeted Therapies
-
CLINICAL_TRIALS study record update · 2026-06-02OPEN-LABEL INDUCTION AND MAINTENANCE STUDY OF ORAL CP-690,550 (TOFACITINIB) IN CHILDREN WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-27IBD-Sleep: A Pilot Study Looking at Changes in Sleep Timing and IBD Symptoms
-
CLINICAL_TRIALS study record update · 2026-04-27A Follow-up Phase II Open-label Study to Evaluate the Long-term Safety and Efficacy Profile of ABX464 Given at 25 mg Once Daily in Subjects With Moderate to Severe Active Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2026-04-27Describing Prescription Patterns in an Ulcerative Colitis Population and Generating an Updated Ulcerative Colitis Treatment Paradigm
-
CLINICAL_TRIALS study record update · 2026-04-27Therapeutic Effect of New Biologics in Crohn's Disease
-
CLINICAL_TRIALS study record update · 2026-04-27Adjunctive Treatment With Vitamin D3 in Patients With Active IBD (ACTIVATED): A Randomized, Double-blind, Placebo-controlled Trial
-
CLINICAL_TRIALS study record update · 2026-04-27An Open-Label Extension Study of Etrasimod in Subjects With Moderately to Severely Active Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2026-04-27An Open-Label Extension Study of Etrasimod in Subjects With Moderately to Severely Active Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2026-04-24Implementing a Multimodal RCT Intervention to Improve the Transition of Patients With Crohn's Disease From Pediatric to Adult Care
-
CLINICAL_TRIALS study record update · 2026-04-24Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation
-
CLINICAL_TRIALS study record update · 2026-04-24Predictors of Response After Induction Therapy With TNF-alpha Inhibitor in Inflammatory Bowel Disease, Comparison to Normal
-
CLINICAL_TRIALS study record update · 2026-04-24A Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled Phase 3, Induction Study to Evaluate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis.
-
CLINICAL_TRIALS study record update · 2026-04-24Phase 2 Platform Trial to Assess the Efficacy and Safety of Long-acting Antibodies as Single Agents and in Combinations for Moderately to Severely Active Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2026-04-23A Phase 2b, Multi-national, Multi-center, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study Followed by a Long-term Extension to Evaluate the Efficacy and Safety of SAR442970 in Adult Participants With Moderate to Severe Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2026-04-23The Effect of VSL#3 (Original De Simone Formulation) Probiotic Preparation on the Bile Acid Metabolism in Patients With Inflammatory Bowel Disease
-
CLINICAL_TRIALS study record update · 2026-04-22A Phase 4 Study Evaluating Moderate to Severely Active Ulcerative Colitis or Crohn's Disease and the Use of Vedolizumab Subcutaneous Within a Community Setting
-
CLINICAL_TRIALS study record update · 2026-04-21A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-8690 in Adult Participants With Moderately to Severely Active Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2026-04-21A Phase Ib Study of Nivolumab in Patients With Autoimmune Disorders and Advanced Malignancies (AIM-NIVO)
-
CLINICAL_TRIALS study record update · 2026-04-21Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2026-04-20Colonoscopic Investigation of the Correlation Between Bowel Wall Inflammation and Luminal Temperature Rise in IBD
-
CLINICAL_TRIALS study record update · 2026-04-20A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3